How NGOs should choose their banks

Ivvnpgj4jwvgbyotrhrnpcqehrahecqaqh6lyc7iqccakuxdlxkvwmwrysdyzqlcko0y6ofisvabrnshbnvsrbct1za1k4oo8jbkm0bafof8giyui8 7pk8ygtcrr1ixewgemdm
By Helen Castell

What should NGOs and charities consider when choosing who to bank with? We spoke with bank officials and organizations' chief financial officers to find out.


Piloting the data revolution

The post-2015 framework currently promises to target people with disabilities, but without better, more accurate data we can’t determine the impact on this group of people, and there’s a risk that, yet again, they will miss out on development initiatives, writes Sightsavers' program delivery monitoring officer in this op-ed.


How to effectively fund civil society

Ricardo Fuentes-Nieva, head of research for Oxfam GB speaks with Devex about the state of civil society in the developing world and how to effectively fund CSO programs and initiatives.


What makes knowledge partnerships for development work

While partnerships are essential to accomplish the global development agenda, proponents argue a knowledge-based one is key to pushing this agenda forward. But what makes knowledge partnerships work? Devex finds out.


Rethinking partnerships for greater shared value

The Levi Strauss Foundation had to form partnerships with NGOs to ensure the sustainability of its programs. It's been quite a process, one in which the actors have had to learn and grow, Executive Director Daniel Lee shares in this video interview for the Future of INGO series.


Maternal mortality: Not just a human rights issue

Maternal mortality is not just a human rights issue; it's an economic and social issue with consequences that cannot be ignored, writes Aslihan Kes, economic and gender specialist at the International Center for Research on Women.


How NGOs can save money on FX

Foreign exchange can represent a huge part of an NGO's financing or banking costs. There are numerous ways to make savings here, but many smaller and midsize organizations are not getting the best deal. Here are 10 questions NGOs should ask to get the best deal from their banks or brokers.


Toward data-driven development: Big improvement or big buzz?

Big data is everywhere in our data-driven society, but access to it remains scarce. How then can we get hold of big data for development purposes? An exclusive commentary from Thomas Roca, a researcher and statistician developing a data visualization portal for the French Development Agency.


Why doing development differently doesn't mean less accountability

Despite consensus on the need for development solutions to adapt to local contexts and political complexities, development practice is finding it hard to reconcile the need for increased flexibility with existing accountability and results requirements. Here's why such a conundrum is not insurmountable.


Building the business case for health sector strengthening

London-based pharmaceutical company GlaxoSmithKline PLC announced a commitment Friday to train more than 9,000 health workers in Ghana, Kenya and Nigeria in partnership with NGOs and in-country governments. What does it take to build the case for private sector investment in health systems?


USAID's top small business contractors for 2014

For only the second year running, USAID has set a worldwide procurement goal for U.S. small businesses — 10 percent of prime contract spending in fiscal 2015. In the latest in our series on top donor agency partners, Devex ranks USAID's 20 largest small business contractors.


Inside Development

Why doing development differently doesn't mean less accountability

Spzsptziwfprudze7o7ep6 pxbioxwrerg92nncpzzjg4q9dcbaknzkeutzcv k0btiipkov3ilqnn6trj0ihbmcjjmyt29mw n7ijkqnytvvvkx2llhhpjhnegtyigykenhnmg

Despite consensus on the need for development solutions to adapt to local contexts and political complexities, development practice is finding it hard to reconcile the need for increased flexibility with existing accountability and results requirements. Here's why such a conundrum is not insurmountable.

Global Views

Time for decisive action on antimicrobial resistance

60tgs2ju0ldhmfrjhobdypt0ym8qoh yz6uk j0znrqpvaar7koyrd44b9ktjtud7mh7y42 ovgowqjss8 fon flbol262npryiuxxizx3mkouxivhr mpjihzf1bhozumwfxq

Although antibiotic resistance is rising to dangerously high levels in all parts of the world, only about one-quarter of countries have national plans to tackle this problem. This is far too few, and needs to change. A guest op-ed from Keiji Fukuda, WHO's assistant director-general for health security.

Search for Articles

Advertisement

Global Goals Work

Advertisement

Focus On: Global Health